The Sinus Dilation Devices Market size is expected to grow at an annual average of 9% during 2021-2027. Chronic sinusitis affects more than 31 million people in the United States. It is more prevalent than heart disease and asthma and has a greater impact on patients’ quality of life than chronic back pain or congestive heart failure. The majority of patients with chronic sinusitis are treated with oral antibiotics and/or nasal steroids, which can increase the risk of antibiotic resistance and cause unwanted side effects such as epistaxis (nose bleeds), nasal ulcers, and nasal and oral infections.
(Get 15% Discount on Buying this Report)
A full report of Sinus Dilation Devices Market is available at: https://www.orionmarketreports.com/sinus-dilation-devices-market/27560/
The following segmentation are covered in this report:
By Product Type
- Balloon Sinus Dilation Devices
- Endoscopes
- Sinuscopes
- Rhinoscopes
- Sinus Stents/Implants
- Functional Endoscopic Sinus Surgery (FESS) Instruments Set
- Others
By End-use
- Hospitals
- ENT Clinics
- Ambulatory Surgery Centres
Company Profile
- Acclarent, Inc.
- Creganna
- Intersect ENT, Inc.
- Johnson & Johnson
- Medtronic Plc
- Meril Life Sciences Private Limited
- Olympus Corporation
- SinuSys Corporation
- Smith & Nephew
- Stryker Corporation
The report covers the following objectives:
- Proliferation and maturation of trade in the global Sinus Dilation Devices Market
- The market share of the global Sinus Dilation Devices Market supply and demand ratio, growth revenue, supply chain analysis, and business overview.
- Current and future market trends that are influencing the growth opportunities and growth rate of the Sinus Dilation Devices Market
- Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Sinus Dilation Devices Market
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
